| Title : Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer's Disease via Modulation of AMPK\/mTOR, Oxidative Stress and Glucose Metabolism - Samman_2023_Pharmaceuticals.(Basel)_16_ |
| Author(s) : Samman WA , Selim SM , El Fayoumi HM , El-Sayed NM , Mehanna ET , Hazem RM |
| Ref : Pharmaceuticals (Basel) , 16 : , 2023 |
| Abstract : Samman_2023_Pharmaceuticals.(Basel)_16_ |
| ESTHER : Samman_2023_Pharmaceuticals.(Basel)_16_ |
| PubMedSearch : Samman_2023_Pharmaceuticals.(Basel)_16_ |
| PubMedID: 37242536 |
Samman WA, Selim SM, El Fayoumi HM, El-Sayed NM, Mehanna ET, Hazem RM (2023)
Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer's Disease via Modulation of AMPK\/mTOR, Oxidative Stress and Glucose Metabolism
Pharmaceuticals (Basel)
16 :
Samman WA, Selim SM, El Fayoumi HM, El-Sayed NM, Mehanna ET, Hazem RM (2023)
Pharmaceuticals (Basel)
16 :